NCT07338981 2026-01-14The Impact of Time-of-day-Dependent Administration of Nivolumab-Ipilimumab (ICI/ICI) Combination on Overall Survival in Adults With Advanced Kidney Cancer: A Pragmatic Multicenter, Randomized Controlled Trial.British Columbia Cancer AgencyPhase 3 Not yet recruiting142 enrolled